NIOX Group (LON:NIOX) Shares Up 1.5% - Still a Buy?

NIOX Group Plc (LON:NIOX - Get Free Report)'s stock price shot up 1.5% during trading on Friday . The stock traded as high as GBX 70 ($0.94) and last traded at GBX 69.40 ($0.94). 649,157 shares changed hands during mid-day trading, a decline of 43% from the average session volume of 1,138,227 shares. The stock had previously closed at GBX 68.40 ($0.92).

Wall Street Analyst Weigh In

Several research firms recently commented on NIOX. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 90 ($1.21) target price on shares of NIOX Group in a report on Tuesday, April 15th. Berenberg Bank reaffirmed a "buy" rating and set a GBX 90 ($1.21) price objective on shares of NIOX Group in a report on Tuesday, April 15th.

NIOX Group Stock Performance

The company has a market cap of £28.50 billion, a PE ratio of 2,864.02 and a beta of 0.92. The firm has a fifty day simple moving average of GBX 67.12 and a 200-day simple moving average of GBX 64.82. The company has a quick ratio of 1.94, a current ratio of 6.31 and a debt-to-equity ratio of 1.10.

Insiders Place Their Bets

In other NIOX Group news, insider Jonathan Emms sold 2,745,925 shares of NIOX Group stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of GBX 65 ($0.88), for a total value of £1,784,851.25 ($2,407,731.35). Also, insider Ian Johnson sold 3,924,630 shares of NIOX Group stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of GBX 65 ($0.88), for a total transaction of £2,551,009.50 ($3,441,264.67). 46.72% of the stock is owned by company insiders.

NIOX Group Company Profile

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.